1,25-Dihydroxyvitamin D3 in the pathogenesis and treatment of osteoporosis
- 1 May 1997
- journal article
- Published by Springer Nature in Osteoporosis International
- Vol. 7 (S3) , 24-29
- https://doi.org/10.1007/bf03194338
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Human 25-Hydroxyvitamin D3-24-Hydroxylase, a Multicatalytic EnzymeBiochemistry, 1996
- Effects of increasing doses of 1α-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic womenJournal of Bone and Mineral Research, 1994
- Treatment of Postmenopausal Osteoporosis with Calcitriol or CalciumNew England Journal of Medicine, 1992
- Vitamin D deficiency and renal calcium transport in the rat.Journal of Clinical Investigation, 1984
- TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUMClinical Endocrinology, 1982
- Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic PatientsNew England Journal of Medicine, 1981
- THE CONTROL OF CALCIUM AND PHOSPHORUS METABOLISM BY THE VITAMIN D ENDOCRINE SYSTEM*Annals of the New York Academy of Sciences, 1980
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- 1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue CultureScience, 1972
- Tracer Experiments on the Effect of Vitamin D on the Skeletal Metabolism of Calcium and PhosphorusActa Physiologica Scandinavica, 1952